ANIP
NASDAQ · Pharmaceuticals
Ani Pharmaceuticals Inc
$73.92
-0.75 (-1.00%)
Open$75.95
Previous Close$74.67
Day High$75.95
Day Low$73.81
52W High$99.50
52W Low$56.71
Volume—
Avg Volume403.0K
Market Cap1.67B
P/E Ratio41.09
EPS$1.94
SectorPharmaceuticals
Analyst Ratings
Strong Buy
14 analysts
Price Target
-50.3% upside
Current
$73.92
$73.92
Target
$36.71
$36.71
$28.36
$36.71 avg
$54.52
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 696.69M | 491.81M | 587.23M |
| Net Income | -21,003,794 | -13,344,214 | 76.98M |
| Profit Margin | -3.0% | -2.9% | 13.1% |
| EBITDA | 64.43M | 43.21M | 125.34M |
| Free Cash Flow | — | — | 59.62M |
| Rev Growth | +41.7% | +41.7% | +23.0% |
| Debt/Equity | 1.46 | 1.46 | 0.51 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $916.31 | +1.47% | 46.4 | 957.52B |
| JNJ | Johnson & Johnson | $239.93 | +1.98% | 22.2 | 594.00B |
| MRK | Merck & Co. Inc. | $119.37 | +2.58% | 16.5 | 301.17B |
| PFE | Pfizer Inc. | $27.28 | +1.19% | 19.7 | 153.36B |
| BMY | Bristol-Myers Squibb Co | $58.94 | +2.70% | 16.5 | 116.58B |
| ZTS | Zoetis Inc | $116.71 | +0.67% | 21.5 | 57.37B |